Tell us about your current research project...
Our research team is interested in understanding how a common viral infection, Epstein Barr Virus (EBV), that infects up to 90% of the general population, may play a role in patients developing MS. Our prior research has shown that EBV produces a protein that is important in turning on genes that have been shown to increase your risk of developing MS. We hope to be able to block this protein with various inhibitors to see if this may change whether these risk genes are turned on. We have also noted that there are differences in the genes that are turned on and off between males and females who are infected with EBV and this may partly explain why females are more prone to getting MS. One of our goals is to try and understand why this difference exists between the sexes and how we may be able to reduce the risks with various therapeutics.